In March, the Lancet published a study showing that all-metal hip implants fail at a rate of 6 percent in five years, compared to the 2 percent seen in plastic or ceramic devices.
(PRWEB) December 20, 2012
Parker Waichman, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, has filed a lawsuit alleging that the Biomet M2a Magnum™ caused various injuries leading to revision surgery in a Missouri man. The suit was filed on November 26th in the U.S. District for the Western District of Missouri, Central Division (Civil Case No. 2:12-cv-4297). Biomet, Inc. and Biomet Orthopedics, LLC have been named as Defendants.
According to the Complaint, the Plaintiff was implanted with the Biomet M2a Magnum™ hip system in both hips. Thereafter, his implants failed, causing severe pain, elevated chromium and cobalt levels and significant economic loss. The suit states that these complications ultimately forced the Plaintiff to undergo a revision surgery to remove the device. The lawsuit also alleges that the procedure itself puts the Plaintiff at additional risk, because revision surgeries are often more complex than the initial implantation.
A total hip replacement consists of an acetabular component, a cup or shell that acts as the hip socket, interacting with a femoral component. The lawsuit points out that, while some hip replacements offer a plastic liner to be used in conjunction with the acetabular cup, the M2a Magnum™ hip implant lacks this option because it uses a “monoblock” system. As a result, the suit alleges that the Biomet M2a Magnum™ forces metal to rub against metal with the full weight of the body, releasing metal ions into the bloodstream.
The lawsuit alleges that the Defendants knew about the risk of premature failure associated with the M2a Magnum™ , but did not convey adequate warnings to the Plaintiff or the public due to their own financial interests. According to the suit, the U.S. Food and Drug Administration (FDA) had received 100 adverse event reports linked to the M2a Magnum™ at the time the Plaintiff received his implants.
Metal-on-metal hip implants have been linked to high rates of implant failure and early revision. In March, The Lancet published a study showing that all-metal hip implants fail at a rate of 6 percent in five years, compared to the 2 percent seen in plastic or ceramic devices. These findings prompted the authors to call an end to their use.
The U.S. Food and Drug Administration (FDA) has also addressed the risks associated with metal-on-metal hip implants. The agency has asked 21 manufacturers to conduct postmarket safety studies on the devices to assess whether they release dangerous amounts of metal ions into the body. Over the summer, an FDA advisory panel met to discuss the pros and cons of the devices. At the conclusion of a three-day meeting, the experts advised that metal hip patients undergo yearly physicals, imaging scans and possible blood screening for metal ions in order to detect complications. Some panelists questioned whether or not metal-on-metal hip replacements should be used at all in the future.
Parker Waichman LLP continues to offer free legal consultations to victims of metal-on-metal hip implant injuries. If you or a loved one experienced premature failure of your implant or other health problems associated with a metal-on-metal hip implant, please contact their office by visiting the firm's Defective Hip Implants page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).
Parker Waichman LLP
Gary Falkowitz, Managing Attorney